STOCK TITAN

EW Healthcare amends Venus Concept (VERO) stake, eyes $2.6M sale to Madryn

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13D/A

Rhea-AI Filing Summary

EW Healthcare Partners and its affiliates filed Amendment No. 16 to their Schedule 13D on Venus Concept, Inc., updating their beneficial ownership and future plans. The group reports beneficial ownership stakes calculated against 1,859,123 common shares outstanding as of November 7, 2025, with individual reporting entities showing up to 21.4% of the class when including convertible and exercisable securities.

On March 16, 2026, EW Healthcare entities agreed a non-binding term sheet with Madryn Asset Management for Madryn to purchase all Venus Concept preferred stock and secured subordinated convertible notes held by the EW Healthcare sellers. The aggregate purchase price is $2,600,000, payable in four cash installments of $650,000 each, due 18, 24, 30 and 36 months after closing. Aside from this contemplated transaction, the reporting group states it has no present plans for other major corporate actions, while reserving flexibility to reassess over time.

Positive

  • None.

Negative

  • None.

Insights

Large holder updates stake and agrees to sell preferred and notes.

EW Healthcare Partners and related entities remain significant holders of Venus Concept, with individual reporting entities showing beneficial ownership up to 21.4% when including convertible preferred, options and notes. Percentages are based on 1,859,123 common shares outstanding as of November 7, 2025.

The key development is a non-binding term sheet under which Madryn Asset Management would acquire all Junior and Senior Preferred Stock and secured subordinated convertible notes held by the EW sellers for $2,600,000, paid in four equal cash installments 18, 24, 30 and 36 months after closing. This shifts who holds influential preferred and debt positions but does not itself change company operations.

Because the term sheet is expressly non-binding and detailed closing mechanics are not included here, the overall signal is neutral. Subsequent company or holder disclosures would be needed to understand if and when the transaction closes and how it affects capital structure or governance.






If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).




schemaVersion:


SCHEDULE 13D




Comment for Type of Reporting Person:
Row 7, 9 and 11. See Item 5 below.


SCHEDULE 13D




Comment for Type of Reporting Person:
Row 7, 9 and 11. See Item 5 below.


SCHEDULE 13D




Comment for Type of Reporting Person:
Row 7, 9 and 11. See Item 5 below.


SCHEDULE 13D




Comment for Type of Reporting Person:
Row 7, 9 and 11. See Item 5 below.


SCHEDULE 13D


EW Healthcare Partners, L.P.
Signature:/s/ R. Scott Barry
Name/Title:Essex Woodlands Fund IX-GP, L.P., Its General Partner, Essex Woodlands IX, LLC, Its General Partner, R. Scott Barry, Manager
Date:03/18/2026
EW Healthcare Partners-A, L.P.
Signature:/s/ R. Scott Barry
Name/Title:Essex Woodlands Fund IX-GP, L.P., Its General Partner, Essex Woodlands IX, LLC, Its General Partner, R. Scott Barry, Manager
Date:03/18/2026
Essex Woodlands Fund IX-GP, L.P.
Signature:/s/ R. Scott Barry
Name/Title:Essex Woodlands IX, LLC, Its General Partner, R. Scott Barry, Manager
Date:03/18/2026
Essex Woodlands IX, LLC
Signature:/s/ R. Scott Barry
Name/Title:R. Scott Barry, Manager
Date:03/18/2026

FAQ

What does EW Healthcare Partners report in its latest Venus Concept (VERO) Schedule 13D/A?

EW Healthcare Partners and affiliates updated their Schedule 13D to reflect current beneficial ownership in Venus Concept. They detail common shares, convertible preferred, options, and notes counted toward their stake, with individual reporting entities showing up to 21.4% of the class on a converted basis.

How large is the Venus Concept (VERO) stake reported by the EW Healthcare group?

The filing shows individual reporting entities with beneficial ownership percentages up to 21.4% of Venus Concept common stock. These percentages are calculated using 1,859,123 shares outstanding as of November 7, 2025, plus shares issuable from specified preferred stock, options, and convertible notes.

What transaction did EW Healthcare and Madryn agree regarding Venus Concept (VERO)?

EW Healthcare entities and Madryn Asset Management agreed a non-binding term sheet for Madryn to buy all Venus Concept Junior and Senior Preferred Stock and certain secured subordinated convertible notes held by EW sellers. The deal would consolidate these securities with Madryn if it closes.

What is the purchase price Madryn would pay for Venus Concept preferred stock and notes?

Madryn would pay an aggregate purchase price of $2,600,000 to the EW selling securityholders. The amount is structured as four cash installments of $650,000 each, due 18, 24, 30, and 36 months after the transaction’s closing date, according to the term sheet.

Is the Venus Concept (VERO) agreement between EW Healthcare and Madryn binding?

The parties signed a Non-Binding Summary of Terms, described as a term sheet, so the agreement is not yet a definitive binding contract. It outlines proposed terms for Madryn to acquire the preferred stock and notes but leaves completion contingent on further steps.

Does EW Healthcare state other plans for its Venus Concept (VERO) investment?

Aside from the contemplated sale of preferred stock and notes to Madryn, the EW Healthcare reporting group states it has no present plan or proposal for the major corporate actions listed in Item 4. However, they indicate they will continue reviewing the business and may consider actions later.
Venus Concept Inc

OTC:VERO

View VERO Stock Overview

VERO Rankings

VERO Latest News

VERO Latest SEC Filings

VERO Stock Data

2.12M
1.83M
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
Canada
TORONTO